Biomeme
Philadelphia, PA, United StatesFounded 2012Industry
Biomeme makes portable PCR devices for field pathogen detection. CBRNE-relevant work is a minor part of its offering according to its website. It is headquartered in Philadelphia, PA, United States.
What it does
Threats covered
Categories
Profile
Biomeme is a Philadelphia diagnostics company founded in 2012 that develops mobile real-time PCR systems for field and point-of-care testing. Its Franklin thermocycler is a rugged, battery-powered, smartphone-connected device that can detect up to 27 targets in one run and give field results in under an hour.
More profile
A March 2024 convertible investment from Robin Hood Ventures is the most recent funding found, and no 2025 or 2026 funding appeared in the sources read. A HigherGov profile lists the company as a federal awardee.
Ownership
Privately held, venture-backed
Parent: none identified
Sources (5)
Not verified or not found
- Federal contract values: not read.
- Biothreat assay panels: not read.
Questions
What does Biomeme do?
Biomeme makes portable PCR devices for field pathogen detection. CBRNE-relevant work is a minor part of its offering according to its website.
Where is Biomeme based?
HQ (as found): Philadelphia, PA. HQ country: US.
Who owns Biomeme?
Privately held, venture-backed. Parent: none identified
Profiles are compiled from public sources and sampled-checked, not fully audited. Last verified 17 October 2026. Report a correction